Medical Care

Global IVD and POCT Market Research Report 2025

The global market for IVD and POCT was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for IVD and POCT is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for IVD and POCT is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for IVD and POCT in Clinics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of IVD and POCT include Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, ARKRAY, Nova Biomedical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for IVD and POCT, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD and POCT.
The IVD and POCT market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IVD and POCT market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD and POCT companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Trinity Biotech
ELITech Group
Response Biomedical
Princeton BioMeditech
Alfa Wassermann
Segment by Type
POCT
IVD
Segment by Application
Clinics
Hospitals
Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD and POCT company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD and POCT Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 POCT
1.2.3 IVD
1.3 Market by Application
1.3.1 Global IVD and POCT Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD and POCT Market Perspective (2020-2031)
2.2 Global IVD and POCT Growth Trends by Region
2.2.1 Global IVD and POCT Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 IVD and POCT Historic Market Size by Region (2020-2025)
2.2.3 IVD and POCT Forecasted Market Size by Region (2026-2031)
2.3 IVD and POCT Market Dynamics
2.3.1 IVD and POCT Industry Trends
2.3.2 IVD and POCT Market Drivers
2.3.3 IVD and POCT Market Challenges
2.3.4 IVD and POCT Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD and POCT Players by Revenue
3.1.1 Global Top IVD and POCT Players by Revenue (2020-2025)
3.1.2 Global IVD and POCT Revenue Market Share by Players (2020-2025)
3.2 Global IVD and POCT Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by IVD and POCT Revenue
3.4 Global IVD and POCT Market Concentration Ratio
3.4.1 Global IVD and POCT Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD and POCT Revenue in 2024
3.5 Global Key Players of IVD and POCT Head office and Area Served
3.6 Global Key Players of IVD and POCT, Product and Application
3.7 Global Key Players of IVD and POCT, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD and POCT Breakdown Data by Type
4.1 Global IVD and POCT Historic Market Size by Type (2020-2025)
4.2 Global IVD and POCT Forecasted Market Size by Type (2026-2031)
5 IVD and POCT Breakdown Data by Application
5.1 Global IVD and POCT Historic Market Size by Application (2020-2025)
5.2 Global IVD and POCT Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America IVD and POCT Market Size (2020-2031)
6.2 North America IVD and POCT Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America IVD and POCT Market Size by Country (2020-2025)
6.4 North America IVD and POCT Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IVD and POCT Market Size (2020-2031)
7.2 Europe IVD and POCT Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe IVD and POCT Market Size by Country (2020-2025)
7.4 Europe IVD and POCT Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IVD and POCT Market Size (2020-2031)
8.2 Asia-Pacific IVD and POCT Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific IVD and POCT Market Size by Region (2020-2025)
8.4 Asia-Pacific IVD and POCT Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IVD and POCT Market Size (2020-2031)
9.2 Latin America IVD and POCT Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America IVD and POCT Market Size by Country (2020-2025)
9.4 Latin America IVD and POCT Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD and POCT Market Size (2020-2031)
10.2 Middle East & Africa IVD and POCT Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa IVD and POCT Market Size by Country (2020-2025)
10.4 Middle East & Africa IVD and POCT Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche IVD and POCT Introduction
11.1.4 Roche Revenue in IVD and POCT Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott IVD and POCT Introduction
11.2.4 Abbott Revenue in IVD and POCT Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson IVD and POCT Introduction
11.3.4 Johnson & Johnson Revenue in IVD and POCT Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Details
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare IVD and POCT Introduction
11.4.4 Siemens Healthcare Revenue in IVD and POCT Business (2020-2025)
11.4.5 Siemens Healthcare Recent Development
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher IVD and POCT Introduction
11.5.4 Danaher Revenue in IVD and POCT Business (2020-2025)
11.5.5 Danaher Recent Development
11.6 Ascensia
11.6.1 Ascensia Company Details
11.6.2 Ascensia Business Overview
11.6.3 Ascensia IVD and POCT Introduction
11.6.4 Ascensia Revenue in IVD and POCT Business (2020-2025)
11.6.5 Ascensia Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories IVD and POCT Introduction
11.7.4 Bio-Rad Laboratories Revenue in IVD and POCT Business (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Details
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux IVD and POCT Introduction
11.8.4 BioMerieux Revenue in IVD and POCT Business (2020-2025)
11.8.5 BioMerieux Recent Development
11.9 ARKRAY
11.9.1 ARKRAY Company Details
11.9.2 ARKRAY Business Overview
11.9.3 ARKRAY IVD and POCT Introduction
11.9.4 ARKRAY Revenue in IVD and POCT Business (2020-2025)
11.9.5 ARKRAY Recent Development
11.10 Nova Biomedical
11.10.1 Nova Biomedical Company Details
11.10.2 Nova Biomedical Business Overview
11.10.3 Nova Biomedical IVD and POCT Introduction
11.10.4 Nova Biomedical Revenue in IVD and POCT Business (2020-2025)
11.10.5 Nova Biomedical Recent Development
11.11 Trividia Health
11.11.1 Trividia Health Company Details
11.11.2 Trividia Health Business Overview
11.11.3 Trividia Health IVD and POCT Introduction
11.11.4 Trividia Health Revenue in IVD and POCT Business (2020-2025)
11.11.5 Trividia Health Recent Development
11.12 Quidel
11.12.1 Quidel Company Details
11.12.2 Quidel Business Overview
11.12.3 Quidel IVD and POCT Introduction
11.12.4 Quidel Revenue in IVD and POCT Business (2020-2025)
11.12.5 Quidel Recent Development
11.13 Accriva
11.13.1 Accriva Company Details
11.13.2 Accriva Business Overview
11.13.3 Accriva IVD and POCT Introduction
11.13.4 Accriva Revenue in IVD and POCT Business (2020-2025)
11.13.5 Accriva Recent Development
11.14 OraSure Technologies
11.14.1 OraSure Technologies Company Details
11.14.2 OraSure Technologies Business Overview
11.14.3 OraSure Technologies IVD and POCT Introduction
11.14.4 OraSure Technologies Revenue in IVD and POCT Business (2020-2025)
11.14.5 OraSure Technologies Recent Development
11.15 Helena Laboratories
11.15.1 Helena Laboratories Company Details
11.15.2 Helena Laboratories Business Overview
11.15.3 Helena Laboratories IVD and POCT Introduction
11.15.4 Helena Laboratories Revenue in IVD and POCT Business (2020-2025)
11.15.5 Helena Laboratories Recent Development
11.16 A. Menarini Diagnostics
11.16.1 A. Menarini Diagnostics Company Details
11.16.2 A. Menarini Diagnostics Business Overview
11.16.3 A. Menarini Diagnostics IVD and POCT Introduction
11.16.4 A. Menarini Diagnostics Revenue in IVD and POCT Business (2020-2025)
11.16.5 A. Menarini Diagnostics Recent Development
11.17 Abaxis (Zoetis)
11.17.1 Abaxis (Zoetis) Company Details
11.17.2 Abaxis (Zoetis) Business Overview
11.17.3 Abaxis (Zoetis) IVD and POCT Introduction
11.17.4 Abaxis (Zoetis) Revenue in IVD and POCT Business (2020-2025)
11.17.5 Abaxis (Zoetis) Recent Development
11.18 Ortho Clinical Diagnostics
11.18.1 Ortho Clinical Diagnostics Company Details
11.18.2 Ortho Clinical Diagnostics Business Overview
11.18.3 Ortho Clinical Diagnostics IVD and POCT Introduction
11.18.4 Ortho Clinical Diagnostics Revenue in IVD and POCT Business (2020-2025)
11.18.5 Ortho Clinical Diagnostics Recent Development
11.19 Phamatech
11.19.1 Phamatech Company Details
11.19.2 Phamatech Business Overview
11.19.3 Phamatech IVD and POCT Introduction
11.19.4 Phamatech Revenue in IVD and POCT Business (2020-2025)
11.19.5 Phamatech Recent Development
11.20 Chembio Diagnostics
11.20.1 Chembio Diagnostics Company Details
11.20.2 Chembio Diagnostics Business Overview
11.20.3 Chembio Diagnostics IVD and POCT Introduction
11.20.4 Chembio Diagnostics Revenue in IVD and POCT Business (2020-2025)
11.20.5 Chembio Diagnostics Recent Development
11.21 Trinity Biotech
11.21.1 Trinity Biotech Company Details
11.21.2 Trinity Biotech Business Overview
11.21.3 Trinity Biotech IVD and POCT Introduction
11.21.4 Trinity Biotech Revenue in IVD and POCT Business (2020-2025)
11.21.5 Trinity Biotech Recent Development
11.22 ELITech Group
11.22.1 ELITech Group Company Details
11.22.2 ELITech Group Business Overview
11.22.3 ELITech Group IVD and POCT Introduction
11.22.4 ELITech Group Revenue in IVD and POCT Business (2020-2025)
11.22.5 ELITech Group Recent Development
11.23 Response Biomedical
11.23.1 Response Biomedical Company Details
11.23.2 Response Biomedical Business Overview
11.23.3 Response Biomedical IVD and POCT Introduction
11.23.4 Response Biomedical Revenue in IVD and POCT Business (2020-2025)
11.23.5 Response Biomedical Recent Development
11.24 Princeton BioMeditech
11.24.1 Princeton BioMeditech Company Details
11.24.2 Princeton BioMeditech Business Overview
11.24.3 Princeton BioMeditech IVD and POCT Introduction
11.24.4 Princeton BioMeditech Revenue in IVD and POCT Business (2020-2025)
11.24.5 Princeton BioMeditech Recent Development
11.25 Alfa Wassermann
11.25.1 Alfa Wassermann Company Details
11.25.2 Alfa Wassermann Business Overview
11.25.3 Alfa Wassermann IVD and POCT Introduction
11.25.4 Alfa Wassermann Revenue in IVD and POCT Business (2020-2025)
11.25.5 Alfa Wassermann Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global IVD and POCT Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of POCT
Table 3. Key Players of IVD
Table 4. Global IVD and POCT Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global IVD and POCT Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global IVD and POCT Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global IVD and POCT Market Share by Region (2020-2025)
Table 8. Global IVD and POCT Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global IVD and POCT Market Share by Region (2026-2031)
Table 10. IVD and POCT Market Trends
Table 11. IVD and POCT Market Drivers
Table 12. IVD and POCT Market Challenges
Table 13. IVD and POCT Market Restraints
Table 14. Global IVD and POCT Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global IVD and POCT Market Share by Players (2020-2025)
Table 16. Global Top IVD and POCT Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD and POCT as of 2024)
Table 17. Ranking of Global Top IVD and POCT Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by IVD and POCT Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of IVD and POCT, Headquarters and Area Served
Table 20. Global Key Players of IVD and POCT, Product and Application
Table 21. Global Key Players of IVD and POCT, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IVD and POCT Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global IVD and POCT Revenue Market Share by Type (2020-2025)
Table 25. Global IVD and POCT Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global IVD and POCT Revenue Market Share by Type (2026-2031)
Table 27. Global IVD and POCT Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global IVD and POCT Revenue Market Share by Application (2020-2025)
Table 29. Global IVD and POCT Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global IVD and POCT Revenue Market Share by Application (2026-2031)
Table 31. North America IVD and POCT Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America IVD and POCT Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America IVD and POCT Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe IVD and POCT Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe IVD and POCT Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe IVD and POCT Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific IVD and POCT Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific IVD and POCT Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific IVD and POCT Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America IVD and POCT Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America IVD and POCT Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America IVD and POCT Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa IVD and POCT Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa IVD and POCT Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa IVD and POCT Market Size by Country (2026-2031) & (US$ Million)
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche IVD and POCT Product
Table 49. Roche Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott IVD and POCT Product
Table 54. Abbott Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. Johnson & Johnson Company Details
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson IVD and POCT Product
Table 59. Johnson & Johnson Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Siemens Healthcare Company Details
Table 62. Siemens Healthcare Business Overview
Table 63. Siemens Healthcare IVD and POCT Product
Table 64. Siemens Healthcare Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 65. Siemens Healthcare Recent Development
Table 66. Danaher Company Details
Table 67. Danaher Business Overview
Table 68. Danaher IVD and POCT Product
Table 69. Danaher Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 70. Danaher Recent Development
Table 71. Ascensia Company Details
Table 72. Ascensia Business Overview
Table 73. Ascensia IVD and POCT Product
Table 74. Ascensia Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 75. Ascensia Recent Development
Table 76. Bio-Rad Laboratories Company Details
Table 77. Bio-Rad Laboratories Business Overview
Table 78. Bio-Rad Laboratories IVD and POCT Product
Table 79. Bio-Rad Laboratories Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 80. Bio-Rad Laboratories Recent Development
Table 81. BioMerieux Company Details
Table 82. BioMerieux Business Overview
Table 83. BioMerieux IVD and POCT Product
Table 84. BioMerieux Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 85. BioMerieux Recent Development
Table 86. ARKRAY Company Details
Table 87. ARKRAY Business Overview
Table 88. ARKRAY IVD and POCT Product
Table 89. ARKRAY Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 90. ARKRAY Recent Development
Table 91. Nova Biomedical Company Details
Table 92. Nova Biomedical Business Overview
Table 93. Nova Biomedical IVD and POCT Product
Table 94. Nova Biomedical Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 95. Nova Biomedical Recent Development
Table 96. Trividia Health Company Details
Table 97. Trividia Health Business Overview
Table 98. Trividia Health IVD and POCT Product
Table 99. Trividia Health Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 100. Trividia Health Recent Development
Table 101. Quidel Company Details
Table 102. Quidel Business Overview
Table 103. Quidel IVD and POCT Product
Table 104. Quidel Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 105. Quidel Recent Development
Table 106. Accriva Company Details
Table 107. Accriva Business Overview
Table 108. Accriva IVD and POCT Product
Table 109. Accriva Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 110. Accriva Recent Development
Table 111. OraSure Technologies Company Details
Table 112. OraSure Technologies Business Overview
Table 113. OraSure Technologies IVD and POCT Product
Table 114. OraSure Technologies Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 115. OraSure Technologies Recent Development
Table 116. Helena Laboratories Company Details
Table 117. Helena Laboratories Business Overview
Table 118. Helena Laboratories IVD and POCT Product
Table 119. Helena Laboratories Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 120. Helena Laboratories Recent Development
Table 121. A. Menarini Diagnostics Company Details
Table 122. A. Menarini Diagnostics Business Overview
Table 123. A. Menarini Diagnostics IVD and POCT Product
Table 124. A. Menarini Diagnostics Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 125. A. Menarini Diagnostics Recent Development
Table 126. Abaxis (Zoetis) Company Details
Table 127. Abaxis (Zoetis) Business Overview
Table 128. Abaxis (Zoetis) IVD and POCT Product
Table 129. Abaxis (Zoetis) Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 130. Abaxis (Zoetis) Recent Development
Table 131. Ortho Clinical Diagnostics Company Details
Table 132. Ortho Clinical Diagnostics Business Overview
Table 133. Ortho Clinical Diagnostics IVD and POCT Product
Table 134. Ortho Clinical Diagnostics Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 135. Ortho Clinical Diagnostics Recent Development
Table 136. Phamatech Company Details
Table 137. Phamatech Business Overview
Table 138. Phamatech IVD and POCT Product
Table 139. Phamatech Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 140. Phamatech Recent Development
Table 141. Chembio Diagnostics Company Details
Table 142. Chembio Diagnostics Business Overview
Table 143. Chembio Diagnostics IVD and POCT Product
Table 144. Chembio Diagnostics Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 145. Chembio Diagnostics Recent Development
Table 146. Trinity Biotech Company Details
Table 147. Trinity Biotech Business Overview
Table 148. Trinity Biotech IVD and POCT Product
Table 149. Trinity Biotech Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 150. Trinity Biotech Recent Development
Table 151. ELITech Group Company Details
Table 152. ELITech Group Business Overview
Table 153. ELITech Group IVD and POCT Product
Table 154. ELITech Group Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 155. ELITech Group Recent Development
Table 156. Response Biomedical Company Details
Table 157. Response Biomedical Business Overview
Table 158. Response Biomedical IVD and POCT Product
Table 159. Response Biomedical Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 160. Response Biomedical Recent Development
Table 161. Princeton BioMeditech Company Details
Table 162. Princeton BioMeditech Business Overview
Table 163. Princeton BioMeditech IVD and POCT Product
Table 164. Princeton BioMeditech Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 165. Princeton BioMeditech Recent Development
Table 166. Alfa Wassermann Company Details
Table 167. Alfa Wassermann Business Overview
Table 168. Alfa Wassermann IVD and POCT Product
Table 169. Alfa Wassermann Revenue in IVD and POCT Business (2020-2025) & (US$ Million)
Table 170. Alfa Wassermann Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 174. Authors List of This Report


List of Figures
Figure 1. IVD and POCT Picture
Figure 2. Global IVD and POCT Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global IVD and POCT Market Share by Type: 2024 VS 2031
Figure 4. POCT Features
Figure 5. IVD Features
Figure 6. Global IVD and POCT Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global IVD and POCT Market Share by Application: 2024 VS 2031
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Others Case Studies
Figure 12. IVD and POCT Report Years Considered
Figure 13. Global IVD and POCT Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global IVD and POCT Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global IVD and POCT Market Share by Region: 2024 VS 2031
Figure 16. Global IVD and POCT Market Share by Players in 2024
Figure 17. Global Top IVD and POCT Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD and POCT as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by IVD and POCT Revenue in 2024
Figure 19. North America IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America IVD and POCT Market Share by Country (2020-2031)
Figure 21. United States IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe IVD and POCT Market Share by Country (2020-2031)
Figure 25. Germany IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific IVD and POCT Market Share by Region (2020-2031)
Figure 33. China IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America IVD and POCT Market Share by Country (2020-2031)
Figure 41. Mexico IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa IVD and POCT Market Share by Country (2020-2031)
Figure 45. Turkey IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE IVD and POCT Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 49. Abbott Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 51. Siemens Healthcare Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 52. Danaher Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 53. Ascensia Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 54. Bio-Rad Laboratories Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 55. BioMerieux Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 56. ARKRAY Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 57. Nova Biomedical Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 58. Trividia Health Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 59. Quidel Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 60. Accriva Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 61. OraSure Technologies Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 62. Helena Laboratories Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 63. A. Menarini Diagnostics Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 64. Abaxis (Zoetis) Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 65. Ortho Clinical Diagnostics Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 66. Phamatech Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 67. Chembio Diagnostics Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 68. Trinity Biotech Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 69. ELITech Group Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 70. Response Biomedical Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 71. Princeton BioMeditech Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 72. Alfa Wassermann Revenue Growth Rate in IVD and POCT Business (2020-2025)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies